SOFTWARE AUTOMATION AND REGRESSION MANAGEMENT SYSTEMS AND METHODS
    1.
    发明申请
    SOFTWARE AUTOMATION AND REGRESSION MANAGEMENT SYSTEMS AND METHODS 有权
    软件自动化和回归管理系统与方法

    公开(公告)号:US20160117235A1

    公开(公告)日:2016-04-28

    申请号:US14525401

    申请日:2014-10-28

    IPC分类号: G06F11/36 H04L29/08

    摘要: An automation and regression management method for testing software in a highly-complex cloud-based system with a plurality of nodes, through an automation and regression management system, includes receiving a plurality of requests for automated test runs on nodes in the highly-complex cloud-based system; managing the plurality of requests by either starting an automated test run on a node or queuing the automated test run if another automated test run is already operating on the node; determining details of each of the automated test runs subsequent to completion; storing the details of each of the automated test runs in a database; and providing the details of each of the automated test runs to a requesting user.

    摘要翻译: 一种用于通过自动化和回归管理系统在具有多个节点的高度复杂的基于云的系统中测试软件的自动化和回归管理方法包括在高度复杂的云中的节点上接收多个对自动测试运行的请求 系统; 通过在节点上启动自动测试运行或者如果另一自动化测试运行已经在节点上运行则排队自动测试运行来管理多个请求; 确定完成后的每个自动测试运行的细节; 将每个自动测试运行的细节存储在数据库中; 并将每个自动测试运行的细节提供给请求用户。

    NANOMECHANICAL BIOMARKERS FOR DISEASE THERAPY
    2.
    发明申请
    NANOMECHANICAL BIOMARKERS FOR DISEASE THERAPY 审中-公开
    用于疾病治疗的纳米生物标志物

    公开(公告)号:US20130266665A1

    公开(公告)日:2013-10-10

    申请号:US13802080

    申请日:2013-03-13

    IPC分类号: G01N33/50

    摘要: A method of treating a patient having cancer includes: (1) providing a biological sample from the patient, the biological sample including multiple cells; (2) detecting a response of the biological sample to a probing element; (3) based on the response, determining test values for the biological sample, the test values being indicative of a nanomechanical characteristic of the cells; (4) deriving a test nanomechanical profile characterizing a distribution of the test values; and (5) based on the test nanomechanical profile, selecting a therapeutic agent to treat the patient.

    摘要翻译: 治疗患有癌症的患者的方法包括:(1)从患者提供生物样品,所述生物样品包括多个细胞; (2)检测生物样品对探测元件的响应; (3)基于响应,确定生物样品的测试值,测试值表示细胞的纳米机械特征; (4)导出表征测试值分布的测试纳米机械轮廓; 和(5)基于测试纳米机械特征,选择治疗剂治疗患者。

    APPARATUS AND METHOD FOR INCREASING DEPTH RANGE AND SIGNAL TO NOISE RATIO IN FOURIER DOMAIN LOW COHERENCE INTERFEROMETRY
    5.
    发明申请
    APPARATUS AND METHOD FOR INCREASING DEPTH RANGE AND SIGNAL TO NOISE RATIO IN FOURIER DOMAIN LOW COHERENCE INTERFEROMETRY 审中-公开
    用于增加深度范围和信号到低域相干干扰中的噪声比的装置和方法

    公开(公告)号:US20120050746A1

    公开(公告)日:2012-03-01

    申请号:US12870825

    申请日:2010-08-29

    IPC分类号: G01B9/02

    摘要: Apparatus, method and data processing for increasing the depth range and signal to noise ratio (SNR) in Fourier domain low coherence interferometry (FD LCI) and in Fourier domain optical coherence tomography (FD OCT) using a 2 dimensional (2D) detector array is provided. The depth range and the noise of the FD LCI and FD OCT depend on the number of pixels in the detector that are used for imaging. As the depth range is proportional and the noise is inversely proportional to the number of pixels, the use of increased number of pixels of a 2D detector array increases the depth range and the signal to noise ratio (SNR) many fold.

    摘要翻译: 使用二维(2D)检测器阵列在傅里叶域低相干干涉测量(FD LCI)和傅立叶域光学相干断层扫描(FD OCT)中增加深度范围和信噪比(SNR)的装置,方法和数据处理是 提供。 FD LCI和FD OCT的深度范围和噪声取决于用于成像的检测器中的像素数。 随着深度范围成比例,噪声与像素数成反比,2D检测器阵列的像素数量的增加使得深度范围和信噪比(SNR)增加了很多倍。